Third-Party Risk

Understanding and mitigating third-party risk in the healthcare sector

Nov 30, 2022

Aymard Jimenez

Research and Due Diligence Specialist, LSEG

Christopher Sindik

Head of Research Consultancy, Refinitiv Due Diligence

Subscribe to Newsletter

Please enter a vaild email.

I would like to receive the Refinitiv Perspectives newsletter.

Please select this checkbox.

I'd like to receive communications about Refinitiv resources, events, products, or services. (Please note you can manage and update your preferences at any time.)

By submitting your details, you are agreeing to receive communications about Refinitiv resources, events, products, or services. You also acknowledge that you have read and understood our

privacy statement.

Thanks for subscribing

You’ve signed up to our weekly newsletter to get the latest Industry insights. You can unsubscribe at any time.

Find us here

Third-party risk

Make sure all of your business relationships are built on solid foundations, satisfy regulators, and also meet shareholder and customer expectations around corporate responsibility, reputational risk, and transparency

Healthcare due diligence

Access the data, technology, reporting and services to manage risks associated with third parties in healthcare, pharmaceutical, medtech and life science companies